IDEA Collider: Innovation & Asymmetric Learning in Pharma cover image

The Misconceptions In The Pharma Industry With John L. Lamattina

IDEA Collider: Innovation & Asymmetric Learning in Pharma

00:00

Could the Dynamics of Our Health Care System Change?

I thought there was some hubris from Gilead when they launched that price and one was proud of it. Maybe, you know, maybe another's a lot of pushback. But just the fact that they were able to get this cure didn't mean that everybody was going to try and take advantage of it. I think there's some sadness that if you look at the number of people with hepatitis C in the States today versus when they launched Sivaldi.

Play episode from 17:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app